|
|
SMFM Special Statement: Curriculum outline on patient safety and quality for maternal-fetal medic...
|
SMFM Statement
|
SMFM, Patient Safety & Quality Committee, Fellowship Committee |
2023 |
|
|
SMFM Statement: Response to the Food and Drug Administration’s withdrawal of 17-alpha hydroxyprog...
|
SMFM Statement
|
SMFM |
2023 |
|
|
Society for Maternal-Fetal Medicine Special Statement: Quality metric on the rate of postpartum d...
|
SMFM Statement
|
SMFM |
2023 |
|
|
SMFM Special Statement: Telemedicine in obstetrics—quality and safety considerations
|
SMFM Statement
|
SMFM |
2023 |
|
|
SMFM Special Statement: A critical examination of abortion terminology as it relates to access an...
|
SMFM Statement
|
SMFM |
2023 |
|
|
SMFM Special Statement: Postpartum visit checklists for normal pregnancy and complicated pregnancy
|
SMFM Statement
|
SMFM |
2022 |
|
|
SMFM Special Statement: Cognitive bias and medical error in obstetrics—challenges and opportunities
|
SMFM Statement
|
SMFM |
2022 |
|
|
SMFM Special Statement: Checklist for pregnancies resulting from in vitro fertilization
|
SMFM Statement
|
SMFM |
2022 |
|
|
SMFM Special Statement: Best-practice recommendations for ultrasound network connectivity
|
SMFM Statement
|
SMFM, T Lee, J Stone, B Iriye, et al, Clinical Informatics Committee |
2022 |
|
|
SMFM Special Statement: Cognitive bias and medical error in obstetrics- Challenges and opportunities
|
SMFM Statement
|
SMFM, F Atallah, RF Hamm, CM Davidson, CA Combs, Patient Safety and Quality Committee |
2022 |
|
|
SMFM Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy: The CHAP Trial
|
SMFM Statement
|
SMFM, Publications Committee |
2022 |
|
|
SMFM Special Statement: Race in maternal-fetal medicine research- Dispelling myths and taking an ...
|
SMFM Statement
|
SMFM |
2022 |
|
|
SMFM Special Statement: A critique of postpartum readmission rate as a quality metric
|
SMFM Statement
|
SMFM |
2022 |
|
|
SMFM Special Statement: Commitment to excellence in obstetrical care, research, and education for...
|
SMFM Statement
|
SMFM |
2022 |
|
|
SMFM Special Statement: COVID-19 research in pregnancy: progress and potential
|
SMFM Statement
|
SMFM |
2021 |
|
|
SMFM Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine
|
SMFM Statement
|
SMFM |
2021 |
|
|
SMFM Special Statement: Surgical safety checklists for cesarean delivery
|
SMFM Statement
|
SMFM |
2021 |
|
|
SMFM Statement: Response to EPPPIC and considerations of the use of progestogens for the preventi...
|
SMFM Statement
|
SMFM |
2021 |
|
|
SMFM Special Statement: Grading of Recommendations Assessment, Development, and Evaluation (GRADE...
|
SMFM Statement
|
SMFM, M Norton, J Kuller, T Metz |
2021 |
|
|
SMFM Special Statement: Checklist for initial management of amniotic fluid embolism
|
SMFM Statement
|
SMFM, CA Combs, DM Montgomery, LE Toner, GA Dildy |
2021 |
